Andrew Kneynsberg, PhD - Publications

2018- Clem Jones Centre for Ageing Dementia Research University of Queensland, Saint Lucia, Queensland, Australia 
 2020-2018 Translational Science and Molecular Medicine Michigan State University, East Lansing, MI 

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Kneynsberg A, Combs B, Christensen K, Morfini G, Kanaan NM. Axonal Degeneration in Tauopathies: Disease Relevance and Underlying Mechanisms. Frontiers in Neuroscience. 11: 572. PMID 29089864 DOI: 10.3389/Fnins.2017.00572  0.84
2017 Kneynsberg A, Kanaan NM. Aging Does Not Affect Axon Initial Segment Structure and Somatic Localization of Tau Protein in Hippocampal Neurons of Fischer 344 Rats. Eneuro. 4. PMID 28785724 DOI: 10.1523/ENEURO.0043-17.2017  0.84
2016 Kneynsberg A, Collier TJ, Manfredsson FP, Kanaan NM. Quantitative and semi-quantitative measurements of axonal degeneration in tissue and primary neuron cultures. Journal of Neuroscience Methods. 266: 32-41. PMID 27031947 DOI: 10.1016/J.Jneumeth.2016.03.004  0.84
2016 Combs B, Kneynsberg A, Kanaan NM. Gene Therapy Models of Alzheimer's Disease and Other Dementias. Methods in Molecular Biology (Clifton, N.J.). 1382: 339-66. PMID 26611599 DOI: 10.1007/978-1-4939-3271-9_25  0.84
2015 Grabinski TM, Kneynsberg A, Manfredsson FP, Kanaan NM. A method for combining RNAscope in situ hybridization with immunohistochemistry in thick free-floating brain sections and primary neuronal cultures. Plos One. 10: e0120120. PMID 25794171 DOI: 10.1371/Journal.Pone.0120120  0.64
2012 Kumar A, Kneynsberg A, Tucholski J, Perry G, van Groen T, Detloff PJ, Lesort M. Tissue transglutaminase overexpression does not modify the disease phenotype of the R6/2 mouse model of Huntington's disease. Experimental Neurology. 237: 78-89. PMID 22698685 DOI: 10.1016/J.Expneurol.2012.05.015  0.64
2010 Perry GM, Tallaksen-Greene S, Kumar A, Heng MY, Kneynsberg A, van Groen T, Detloff PJ, Albin RL, Lesort M. Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2 mouse model of Huntington's disease. Human Molecular Genetics. 19: 3354-71. PMID 20558522 DOI: 10.1093/Hmg/Ddq247  0.64
Show low-probability matches.